The Clinical Respiratory Journal · 2018 · 51 citations · 37 references
MedicineOncologyPathologyCancer ImmunologyCancer ScreeningEarly DetectionAutoantibodiesCancer DetectionCancer Early DetectionLung CancerTumor AntigensTumor-associated AntigensAutoantibody AssaysDiagnostic SensitivityEarly Cancer Detection MarkersEarly DiagnosisLung Cancer PathologyLung Cancer ScreeningPulmonary Nodule DiagnosisTissue Autoantibodies
OBJECTIVES: Autoantibodies tumor-associated antigens (TAAs) could be a valuable tool for the diagnosis or early detection of cancer due to their relatively high specificity and stability. The purpose of this study is to detect the level of tumor-associated autoantibodies in lung cancer and assess the diagnostic potential of autoantibodies in screening strategy for early stage lung cancer. MATERIALS AND METHODS: Levels of tumor-associated autoantibodies (AAbs) were measured against a panel of seven TAAs (p53, PGP9.5, SOX2, GAGE7, GBU4-5, CAGE and MAGEA1) in 397 patients with pulmonary lesions (305 with newly diagnosis of NSCLC, 47 with SCLC and 45 with benign nodule) and 74 control persons without any nodules in the lung after chest MDCT scan. The sensitivity, specificity for patients and control persons, positive rate of the panel in different pathology, stage, size of lesion, age and gender were compared and analyzed. RESULTS: The AAbs panel could distinguish malignant lesions from benign lesions and control people, with sensitivity of 56.53% and specificity of 91.60%. The specificity could be further increased to 95.80%, when combined with CT. The AAbs also showed high diagnostic value of malignant nodule, and it would be a new method for judgment of malignant nodules that are less than 8 mm in diameter. No significant differences were seen based on pathology, NSCLC stages, tumor size, age or gender. CONCLUSION: This assay confirms the value of AAbs panel as a diagnostic tool combined with CT scan.
37
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
SEER Cancer Statistics Review, 1975-2003
Lynn A. G. Ries, D. Harkins, Martin Krapcho et al. · ScholarWorks - Georgia State University (Georgia State University) · 2006 · 11.5K citations · Full text
Medicine, Biostatistics, Oncology +12
Peter Goldstraw, John Crowley, Kari Chansky et al. · Journal of Thoracic Oncology · 2007 · 3.7K citations
The Global Burden of Cancer 2013
Christina Fitzmaurice, Daniel Dicker, Amanda Pain et al. · JAMA Oncology · 2015 · 2.8K citations · Full text
Early Lung Cancer Action Project: overall design and findings from baseline screening
Claudia I. Henschke, Dorothy I. McCauley, David F. Yankelevitz et al. · The Lancet · 1999 · 2.5K citations · Full text